{
  "slug": "lamin",
  "name": "Lamin",
  "yc_id": 27092,
  "batch": "Summer 2022",
  "website": "https://lamin.ai",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:18:40.661854",
    "website": "https://lamin.ai",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 1421.59,
      "final_url": "https://lamin.ai/",
      "redirected": true,
      "checked_at": "2025-10-17T01:18:42.083454"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "lamin.ai",
      "registrar": "NAMECHEAP INC",
      "creation_date": "2022-04-07T13:51:21",
      "expiration_date": "2026-04-07T13:51:21",
      "domain_age_days": 1288,
      "domain_age_years": 3.5,
      "name_servers": [
        "nina.ns.cloudflare.com",
        "brad.ns.cloudflare.com"
      ]
    },
    "social_links": {
      "twitter": "https://x.com/laminlabs",
      "linkedin": "https://www.linkedin.com/company/laminlabs",
      "github": "https://github.com/laminlabs",
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": true,
      "x_frame_options": true,
      "x_content_type_options": true,
      "x_xss_protection": true,
      "referrer_policy": true,
      "security_score": 100,
      "server": "cloudflare"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:56.062847",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0-claude",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T10:53:20.902683",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "Increasing biologics R&D spending",
        "AI/ML adoption in life sciences",
        "Open science and data sharing initiatives"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Open-source framework creates network effects and community lock-in, with API-first architecture enabling ecosystem development",
      "differentiation": "Bridges wet lab and dry lab workflows with open-source approach, unlike proprietary platforms",
      "competitive_advantages": [
        "Open-source community adoption",
        "API-first scalable architecture"
      ],
      "competitive_vulnerabilities": [
        "Large incumbents with established customer relationships",
        "Open-source model limits monetization options"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS",
      "scalability": "high",
      "capital_intensity": "low"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "3.5 year domain age suggests traction",
        "Y Combinator validation"
      ],
      "growth_bottlenecks": [
        "Complex enterprise sales cycles",
        "Need for specialized technical expertise"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "medium",
      "execution_risk": "high",
      "overall_risk_score": 6,
      "key_risks": [
        "Competition from well-funded incumbents",
        "Long enterprise adoption cycles",
        "Open-source monetization challenges"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Large addressable market in life sciences",
        "Open-source community potential",
        "API-first architecture enables platform effects"
      ],
      "concerns": [
        "Intense competition from established players",
        "Complex customer acquisition in enterprise biotech"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Benchling",
        "DNAnexus"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Focus on specific use case verticals",
        "Build enterprise sales capabilities"
      ],
      "expansion_opportunities": [
        "Pharma partnership integrations",
        "Academic institution collaborations"
      ]
    },
    "tokens_used": {
      "input": 657,
      "output": 533,
      "total": 1190,
      "estimated_cost": 0.009966
    },
    "status": "success"
  },
  "phase8_complete": true
}